These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. How the autoimmune response to acetylcholine receptor impairs neuromuscular transmission in myasthenia gravis and its animal model. Lindstrom J. Fed Proc; 1978 Dec; 37(14):2828-30. PubMed ID: 214352 [No Abstract] [Full Text] [Related]
3. [Physiopathology of myasthenia gravis. A review (author's transl)]. Bergmans J. Ann Chir; 1980 Mar; 34(3):147-57. PubMed ID: 6245616 [No Abstract] [Full Text] [Related]
4. [Conceptual aspects of myasthenia gravis]. Ledro Molina D, Avilés Mejías S, Garrido Peralta M. Rev Clin Esp; 1981 Oct 15; 163(1):13-6. PubMed ID: 6276939 [No Abstract] [Full Text] [Related]
6. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice. Klooster R, Plomp JJ, Huijbers MG, Niks EH, Straasheijm KR, Detmers FJ, Hermans PW, Sleijpen K, Verrips A, Losen M, Martinez-Martinez P, De Baets MH, van der Maarel SM, Verschuuren JJ. Brain; 2012 Apr 15; 135(Pt 4):1081-101. PubMed ID: 22396395 [Abstract] [Full Text] [Related]
7. Pathogenesis of myasthenia gravis as a disorder of acetylcholine receptors. Drachman DB, Pestronk A, Stanley EF. Adv Cytopharmacol; 1979 Apr 15; 3():237-44. PubMed ID: 382787 [No Abstract] [Full Text] [Related]
8. Insights in the autoimmunity of myasthenia gravis. De Baets MH. Autoimmunity; 2010 Aug 15; 43(5-6):341-3. PubMed ID: 20380585 [Abstract] [Full Text] [Related]
9. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction. Cole RN, Reddel SW, Gervásio OL, Phillips WD. Ann Neurol; 2008 Jun 15; 63(6):782-9. PubMed ID: 18384168 [Abstract] [Full Text] [Related]
10. [Myasthenia, a model of a disease caused by auto-antibodies]. Goulon M, Gajdos P, Goulon-Goëau C. Ann Med Interne (Paris); 1987 Jun 15; 138(6):444-61. PubMed ID: 2829682 [No Abstract] [Full Text] [Related]
12. The role of humoral immunity in myasthenia gravis. Zurn AD, Fulpius BW. Prog Brain Res; 1979 Jun 15; 49():435-40. PubMed ID: 229518 [No Abstract] [Full Text] [Related]
13. Myasthenia gravis: prototype of the antireceptor autoimmune diseases. Schönbeck S, Chrestel S, Hohlfeld R. Int Rev Neurobiol; 1990 Jun 15; 32():175-200. PubMed ID: 1706686 [No Abstract] [Full Text] [Related]
14. Unravelling the pathogenesis of myasthenia gravis. Vincent A. Nat Rev Immunol; 2002 Oct 15; 2(10):797-804. PubMed ID: 12360217 [Abstract] [Full Text] [Related]
15. [alpha-Bungarotoxin and acetylcholine receptor (author's transl)]. Takamori M, Ishii N, Tsujihata M, Mori M, Kasai M. No To Shinkei; 1977 Jun 15; 29(6):597-607. PubMed ID: 334200 [No Abstract] [Full Text] [Related]
16. Detection of anti-acetylcholine receptor factors in serum and thymus from patients with myasthenia gravis. Mittag T, Kornfeld P, Tormay A, Woo C. N Engl J Med; 1976 Mar 25; 294(13):691-4. PubMed ID: 1250280 [Abstract] [Full Text] [Related]
17. [Immunologic studies of the role of cholinergic receptors in the pathogenesis of myasthenia gravis]. Członkowski A, Członkowska A. Neurol Neurochir Pol; 1978 Mar 25; 12(5):633-7. PubMed ID: 214726 [No Abstract] [Full Text] [Related]
18. Myasthenia gravis and acetylcholine receptor: autoimmunity and steroid effects. Abramsky O. Int J Neurol; 1980 Mar 25; 14(1):25-34. PubMed ID: 6293989 [No Abstract] [Full Text] [Related]
19. Myasthenia gravis: a personal view of pathogenesis and mechanism, part 1. Simpson JA. Muscle Nerve; 1978 Mar 25; 1(1):45-56. PubMed ID: 377070 [Abstract] [Full Text] [Related]
20. Immunobiology of myasthenia gravis, experimental autoimmune myasthenia gravis, and Lambert-Eaton syndrome. Lindstrom J. Annu Rev Immunol; 1985 Mar 25; 3():109-31. PubMed ID: 2998417 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]